08037 CH BIOTECH SER
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.33X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 16.4% | Net Margin | N/A |
| Total Debt/Equity | 70.9% | Return on Equity | N/A |
| Price/Book | 2.87X | Return on Assets | N/A |
| (HKD 0.780) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -198.15 | -95.45 | 258.09 | 19.39 | 30.17 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -107.6 | -137.0 | +1,231.4 | -35.8 | +130.5 |
| Earnings Per Share (HKD) | -0.205 | -0.099 | 0.268 | 0.02 | 0.031 |
| Earnings Per Share Growth (%) | -106.5 | -137.0 | +1,232.8 | -35.6 | +130.3 |
| Dividend Per Share (HKD) | No dividend | No dividend | 0.010 | No dividend | No dividend |
| P/E* (X) | N/A | N/A | 2.91 | 38.81 | 25.00 |
| Yield (%) | N/A | N/A | 1.28 | N/A | N/A |
| Dividend Share (%) | N/A | N/A | 3.73 | N/A | N/A |
| Book NAV (HKD) | 0.272 | 0.480 | 0.626 | 0.411 | 0.355 |
| Auditors' Opinion | Qualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 70.509 | 211.985 | -66.7 | 1,852 |
| Operating Result | -252.689 | -134.641 | +87.7 | 864.228 |
| Associates | 0 | -7.678 | -100.0 | -4.18 |
| Profit Before Taxation | -252.797 | -142.025 | +78.0 | 862.826 |
| Taxation | -0.943 | -1.319 | -28.5 | 157.258 |
| Profit /( Loss) After Taxation | -251.854 | -140.706 | +79.0 | 705.568 |
| Minority Interests | -53.708 | -45.259 | +18.7 | 447.481 |
| Net Profit | -198.146 | -95.447 | +107.6 | 258.087 |
| Earnings Per Share () | -0.2046 | -0.0991 | +106.5 | 0.2679 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0100 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
